Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
ReposiTrak Inc. CEO Randall K. Fields executed automated sales of 7,500 shares of common stock between March 2 and March 4, 2026, through holdings in RK Fields Charitable 2022, LLC, realizing $64,795. The company also disclosed product development, an expanded industry partnership and a quarterly dividend while shares trade near a 52-week low.
Turning Point Brands CFO Andrew Flynn completed a series of insider transactions in early March 2026 that included both purchases and sales of company shares. Flynn sold 2,000 shares on March 4 for $195,140, after acquiring larger tranches on March 2 and 3. The filings coincide with the company’s strong fourth-quarter 2025 results and a recent shar…
Jana Partners Management, LP executed three separate disposals of Mercury Systems Inc. (NASDAQ: MRCY) common stock between March 2 and March 4, 2026, selling 452,057 shares for a total of $41.4 million at prices between $89.68 and $94.05. The sales were reported as part of portfolio rebalancing. The transactions come amid robust quarterly results f…
TransMedics Group Inc. Chief Financial Officer Gerardo Hernandez sold a total of 7,611 shares of the company’s common stock across two transactions in early March for roughly $1.12 million, after exercising options to acquire 7,236 shares. The moves leave Hernandez with 14,689 shares directly owned. The stock is trading near its 52-week high follow…
Adam C. Spice, Chief Financial Officer of Rocket Lab Corp (RKLB), sold 59,714 shares on March 2, 2026, in a pre-arranged sell-to-cover transaction to meet tax-withholding obligations tied to restricted stock unit vesting. The trades, executed at weighted average prices between $66.8288 and $70.617, generated roughly $4.3 million in proceeds. The st…
Clear Secure Chief Accounting Officer Dennis W. Liu sold 7,950 Class A shares on March 2, 2026, generating $386,131 at $48.57 per share. The transaction was carried out automatically under a Rule 10b5-1 plan adopted November 26, 2025, and was disclosed in a Form 4 signed March 4, 2026. The company’s shares are trading close to a 52-week high after …
Trinity Capital Inc. (NASDAQ:TRIN) CEO, President and CIO Kyle Steven Brown purchased 3,333 shares at $14.90 per share on March 2, 2026, a transaction valued at $49,661. The shares trade at $15.11, giving Brown an immediate paper gain. The filing also corrects a prior December 17, 2025 Form 4 that misstated certain holdings. Trinity Capital reporte…
Ronald E. Estes, a director at Trinity Capital Inc. (NASDAQ: TRIN), purchased 200 shares on March 3, 2026, at $14.73 per share for a total of $2,946. The stock trades at $15.11 following the purchase. The firm recently reported fourth-quarter 2025 results that beat expectations and committed $50 million in growth capital to Dwelly, a London-based p…
Q2 Holdings, Inc. executive Kirk L. Coleman completed stock sales totaling $1,932,853 to satisfy tax liabilities related to vesting restricted stock units, while also receiving newly vested performance-based shares. The moves come amid a six-month, 37% slide in the company’s share price and follow a quarterly report that beat revenue and adjusted E…
Q2 Holdings, Inc. (NASDAQ: QTWO) Chief People Officer Kimberly Anne Rutledge sold 23,829 shares of common stock on March 3 and 4, 2026, in transactions mandated to satisfy tax withholding obligations. The sales, reported on an SEC Form 4, were executed at weighted average prices between $49.72 and $49.75 per share, totaling approximately $1.18 mill…
Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold a total of 24,233 shares of company stock on March 2 and March 3, 2026, through transactions disclosed on a Form 4 filing. The sales were made under a Rule 10b5-1 trading plan adopted August 11, 2025. The company recently reported Q4 2025 results that beat expectations and saw …
Zevia PBC director Spence Padraic L. sold 40,000 shares of Class A common stock on March 3, 2026, for a weighted average price between $1.43 and $1.45, totaling $57,516. After the sale, Spence holds 1,555,417 shares directly, including 71,827 restricted stock units. The transaction arrives amid mixed fourth-quarter 2025 results: an EPS of -$0.02 th…
AH Realty Trust director Frederick Blair Wimbush purchased 10,000 shares of the company's common stock on March 3, 2026, for $61,900. The REIT's shares trade at $6.36 and yield 8.81% in dividends, a payout maintained for 13 consecutive years. Wimbush's direct and LTIP holdings are detailed in an SEC filing. Separately, Armada Hoffler Properties rep…
Xencor Inc. reported an insider sale by President and CEO Bassil I. Dahiyat, who sold 6,758 shares on March 3, 2026, for $80,387. Filings show Dahiyat also received restricted stock units and a large option grant that vest over multi-year schedules. Separately, Xencor is negotiating a U.S. royalty payment dispute with Alexion while extending a roya…
Xencor Inc. reported an insider sale by its Senior Vice President and Chief Scientific Officer, alongside disclosures of restricted stock units and option awards. The company is managing a U.S. royalty dispute over Ultomiris while extending its U.S. royalty term until December 2028 and plans a busy 2026 clinical agenda for its XmAb pipeline.
Xencor Inc. (NASDAQ:XNCR) reported an insider sale by SVP and General Counsel Celia Eckert on March 3, 2026, and disclosed an associated equity award and prior acquisition. The transactions come as the stock has risen about 49% over six months but remains down roughly 17% year-to-date. Separately, corporate developments around an Ultomiris royalty …
Alnylam Pharmaceuticals Chief Executive Officer Yvonne Greenstreet sold $2.23 million of company stock on March 2, 2026, while simultaneously receiving multiple equity awards and long-dated options. The transactions occur against a backdrop of solid profitability signals, a high price-to-earnings ratio, and recent quarterly results that beat EPS ex…
Allbirds Chief Executive Officer Joseph Vernachio sold 4,413 shares of Class A common stock on March 3, 2026, in transactions executed to cover tax withholding tied to restricted stock units. The sales, disclosed on a Form 4 filing, totaled $11,872 at a weighted average price of $2.69. The move comes as Allbirds contends with a 22% revenue decline …
Allbirds CFO Ann Mitchell sold 2,200 shares of Class A stock on March 3, 2026, to meet tax withholding obligations tied to vested restricted stock units. The disposal occurred while shares trade near a 52-week low and as the company accelerates a strategy to exit most U.S. full-price retail locations in favor of digital, wholesale and international…
Artivion President and CEO James P. Mackin sold 17,887 shares on March 3, 2026, to satisfy tax withholding tied to the vesting of performance stock units. The sale followed a one-third vesting of PSUs on March 2, 2026; Mackin continues to hold a substantial stake in the company. Separately, Artivion reported Q4 2025 earnings that beat EPS and adjus…
Richard T. Thigpen, Senior Vice President for Corporate Citizenship at Public Service Enterprise Group (NYSE: PEG), sold 4,700 shares on March 3, 2026, for proceeds of $390,100. The trade occurred close to the stock's recent trading level and follows quarterly results that met analyst expectations. Market valuation flags and a recent analyst target…
Jorey Chernett, a roughly 10% owner of Airsculpt Technologies, reported purchases of common stock totaling $192,900 in recent Form 4 filings. The acquisitions were executed on March 3 and March 4, 2026, leaving Chernett with 6,352,611 directly owned shares as the stock trades near its 52-week low of $1.51.
Kratos Defense & Security Solutions CFO Deanna H. Lund sold 4,800 shares on March 2, 2026, under a pre-arranged 10b5-1 trading plan for proceeds totaling $456,394. The company simultaneously disclosed business developments including a roughly $7 million Counter-UAS production contract, deployment of its OpenSpace Platform for small-satellite servic…
Artivion Inc. Chief Commercial Officer John E. Davis sold 4,573 shares on March 3, 2026 to satisfy tax withholding tied to vested performance stock units, while receiving 28,845 shares on March 2, 2026 from the same award. The transactions leave Davis with 230,794 shares. The insider activity comes as the stock trades at $38.50, after a year-to-dat…
Artivion executive Lance A. Berry sold 6,316 shares on March 3, 2026, to satisfy tax liabilities arising from the vesting of performance stock units. The sale followed a March 2, 2026 grant of 40,874 shares valued at $0 and leaves Berry with 210,827 directly owned shares. The trades come amid favorable fourth-quarter 2025 results and an analyst pri…
